Trend over time on knowledge of the health effects of cigarette smoking and smokeless tobacco use in Bangladesh: Findings from the International Tobacco Control Policy Evaluation Bangladesh Surveys.


Journal

Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440

Informations de publication

Date de publication:
11 2023
Historique:
revised: 04 07 2023
received: 13 01 2023
accepted: 26 07 2023
medline: 13 11 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Cigarette smoking and smokeless tobacco (ST) use are prevalent in Bangladesh. This longitudinal study examined how knowledge of the health effects of smoking and ST use in Bangladesh has changed overtime with the country's acceleration of tobacco control efforts. Data were analysed from the International Tobacco Control Survey, a nationally representative longitudinal study of users and non-users of tobacco (aged 15 and older) in Bangladesh, across four waves conducted in 2009 (n = 4378), 2010 (n = 4359), 2012 (n = 4223) and 2015 (n = 4242). Generalised estimating equations assessed the level of knowledge about harms of tobacco use across four waves. Multivariable logistic regressions assessed whether knowledge of health effects from cigarette smoking and ST use in 2015 differed by user group. In 2015 survey, most tobacco users were aware that cigarette smoking causes stroke (92%), lung cancer (97%), pulmonary tuberculosis (97%) and ST use causes mouth cancer (97%) and difficulty in opening mouth (80%). There were significant increases in the total knowledge score of smoking related health harm from 2010 to 2012 (mean difference = 0.640; 95% confidence interval [CI] 0.537, 0.742) and 2012 to 2015 (mean difference = 0.555; 95% CI 0.465, 0.645). Participants had greater odds of awareness for ST health effects from 2010 to 2015. The results suggest that increasing efforts of awareness policy interventions is having a positive effect on tobacco-related knowledge in Bangladesh. These policy initiatives should be continued to identify optimal methods to facilitate behaviour change and improve cessation of smoking and ST use.

Identifiants

pubmed: 37565295
doi: 10.1111/dar.13735
pmc: PMC11031133
mid: NIHMS1962736
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1838-1849

Subventions

Organisme : NCI NIH HHS
ID : P01 CA138389
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA200512
Pays : United States

Informations de copyright

© 2023 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.

Références

BMJ. 2004 Jun 26;328(7455):1538
pubmed: 15198947
Tob Control. 2003 Sep;12 Suppl 2:ii9-14
pubmed: 12878768
Thorac Surg Clin. 2013 May;23(2):103-12
pubmed: 23566962
Int J Epidemiol. 2021 Mar 3;50(1):346-351
pubmed: 33351919
Lancet Oncol. 2008 Jul;9(7):667-75
pubmed: 18598931
Tob Control. 2010 Oct;19 Suppl 2:i18-23
pubmed: 20935195
Nicotine Tob Res. 2019 Aug 19;21(9):1162-1171
pubmed: 29790998
Am J Public Health. 1994 Mar;84(3):399-404
pubmed: 8129055
Tob Control. 2019 May;28(3):261-267
pubmed: 29895704
Asian Pac J Cancer Prev. 2011;12(5):1233-8
pubmed: 21875273
Int J Environ Res Public Health. 2016 Aug 25;13(9):
pubmed: 27571090
Tob Control. 2019 May;28(Suppl 1):s20-s30
pubmed: 29674513
BMC Med. 2015 Aug 17;13:194
pubmed: 26278072
Indian J Cancer. 2014 Dec;51 Suppl 1:S33-8
pubmed: 25526246
Health Educ Res. 1992 Mar;7(1):107-16
pubmed: 10148735
Asia Pac J Public Health. 2015 Mar;27(2):NP2197-209
pubmed: 22652250

Auteurs

Eva Naznin (E)

School of Medicine and Public Health, The University of Newcastle, Newcastle, Australia.

Johnson George (J)

Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.

Pete Driezen (P)

Department of Psychology, University of Waterloo, Waterloo, Canada.

Kerrin Palazzi (K)

Hunter Medical Research Institute, Newcastle, Australia.

Olivia Wynne (O)

Hunter Medical Research Institute, Newcastle, Australia.

Nigar Nargis (N)

Surveillance and Healthy Equity Science, American Cancer Society, Washington, USA.

Geoffrey T Fong (GT)

School of Public Health Sciences, University of Waterloo, Waterloo, Canada.

Billie Bonevski (B)

Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH